Circulating Tumor Cells (CTC)
Latest information on Circulating Tumor Cell (CTC) technology for clinical cancer management
Pages
Circulating Tumor Cell Home
Important publications
CTC Patents
Commercial CTC Technologies
CTC resources
Search This Blog
Saturday, April 19, 2014
Circulating Tumor Cell Counts Are Prognostic of Overall Survival in SWOG S0421: A Phase III Trial of Docetaxel With or Without Atrasentan for Metastatic Castration-Resistant Prostate Cancer
Circulating Tumor Cell Counts Are Prognostic of Overall Survival in SWOG S0421: A Phase III Trial of Docetaxel With or Without Atrasentan for Metastatic Castration-Resistant Prostate Cancer
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment